{
  "retracted": false,
  "timestamp": 1421798400000,
  "updates": [
    {
      "timestamp": 1586532840278,
      "identifier": {
        "doi": "10.1007/s10549-015-3263-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10549-013-2810-9"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure"
}
